Chris Roberts

Christopher Graham Roberts is currently the Chairman of TEDI-London.
He is also a Non-Executive Director at Sigma Healthcare Ltd., a Director at Cochlear Foundation Ltd., a Non-Executive Director at Clarity Pharmaceuticals Ltd., a Director at Nutromics Pty Ltd., a Non-Executive Director at Atmo Biosciences Ltd., an Independent Non-Executive Director at HealthCo Healthcare & Wellness REIT, a Non-Executive Director at Hmc Capital Partners Fund I, and a Professor at Arizona State University, The University of New South Wales, and King's College London.
He is a Member of the Governors Board at Centenary Institute and a Member of Innovation Australia.
Formerly, Dr. Roberts served as the President, CEO & Executive Director of Cochlear Ltd.
from 2004 to 2015.
He was also the Chairman of Sirtex Medical Pty Ltd.
from 2000 to 2002, the Executive Chairman of OncoSil Medical Ltd.
from 2016 to 2021, the Chairman of Research Australia Ltd.
from 2004 to 2010, the President, Director & Executive Vice President of ResMed, Inc. from 1992 to 2017, the President of BGS Medical from 1976 to 1992, and a Member of the National Health & Medical Research Council from 2003 to 2006.
Dr. Roberts completed his undergraduate and doctorate degrees at The University of New South Wales and holds an MBA from Macquarie University.